Kouassi B, N'Gom A, Horo K, Godé C, Ahui B, Emvoudou N M L, Koffi N, Anon J C, Konaté K F, Itchi M, Koffi M O, Ano A, Manewa S F, Gro Bi A, Aka-Danguy E, Gnazé A, Touré K
Service de pneumologie, CHU de Cocody, Abidjan BP 22 V13, 1105 Abidjan, Côte d'Ivoire.
Rev Mal Respir. 2013 Sep;30(7):549-54. doi: 10.1016/j.rmr.2013.01.003. Epub 2013 Jan 30.
Correlation of the manifestations of tuberculosis and the degree of immunosuppression in patients with HIV.
The advent of HIV has contributed to the increase in the number of people with tuberculosis. The clinical and paraclinical of TB/HIV co-infected are polymorphic and function of immune status.
To determines the clinical and paraclinical characteristics of TB related to different levels of CD4 lymphocytes.
A retrospective case series based on analysis of 450 patients with both TB/HIV co-infections. It focused on the records of patients with pulmonary smear-positive (TPM +) with a positive HIV status. The effect of immunosuppression was analyzed in groups based on the CD4 count (<200/mm(3), of 200-350/mm(3) and>350/mm(3)), in a chronological fashion from April to September 2010 until there were 150 patients in each CD4 group.
Among the 450 patients, 71.1% were between 25 and 45years old. The clinical signs were more significant as the level of CD4 fell. The clinical signs were predominantly fever (93%) and weight loss (62.7%). Pulmonary cavitation (59.3%), infiltrates (38.7%) and the location of the lesions at the lung apex (72%) were more common in the third group patients. By contrast, extra pulmonary lesions (mediastinal lymphadenopathy, pleurisy) and normal x-ray (9.3%) were more frequent in patients of the first group. The scarcity of cavitations (22.3% compared to 59.3% CD4>350) and the increase in associated lesions became more marked if patients were immunocompromised. Hematologic, hepatic, renal disorders were more frequent and severe in the most immunocompromised patient group.
HIV-associated tuberculosis has an atypical clinical, radiological, biological presentation and is more severe when there is significant immunosuppression.
HIV的出现导致结核病患者数量增加。结核/艾滋病病毒合并感染的临床和辅助检查表现具有多态性,且是免疫状态的函数。
确定与不同水平CD4淋巴细胞相关的结核病的临床和辅助检查特征。
基于对450例结核/艾滋病病毒合并感染患者的分析进行回顾性病例系列研究。重点关注肺部涂片阳性(TPM+)且HIV状态为阳性的患者记录。根据CD4计数(<200/mm³、200 - 350/mm³和>350/mm³)将患者分为几组,按时间顺序分析免疫抑制的影响,时间跨度为2010年4月至9月,直至每个CD4组有150例患者。
450例患者中,71.1%年龄在25至45岁之间。随着CD4水平下降,临床症状更明显。临床症状主要为发热(93%)和体重减轻(62.7%)。第三组患者中肺部空洞形成(59.3%)、浸润(38.7%)以及病变位于肺尖(72%)更为常见。相比之下,第一组患者肺外病变(纵隔淋巴结肿大、胸膜炎)和X线正常(9.3%)更为频繁。如果患者免疫功能低下,空洞形成较少(与CD4>350时的59.3%相比为22.3%)且相关病变增加更为明显。血液学、肝脏、肾脏疾病在免疫功能最低下的患者组中更频繁且更严重。
HIV相关结核病具有非典型的临床、放射学、生物学表现,且在存在显著免疫抑制时病情更严重。
HIV患者结核病表现与免疫抑制程度的相关性
结核病表现与HIV患者免疫抑制程度的相关性
HIV的出现导致结核病患者数量增加。结核/艾滋病病毒合并感染的临床和辅助检查表现具有多态性,且是免疫状态的函数。
确定与不同水平CD4淋巴细胞相关的结核病的临床和辅助检查特征。
基于对450例结核/艾滋病病毒合并感染患者的分析进行回顾性病例系列研究。重点关注肺部涂片阳性(TPM+)且HIV状态为阳性的患者记录。根据CD4计数(<200/mm³、200 - 350/mm³和>350/mm³)将患者分为几组,按时间顺序分析免疫抑制的影响,时间跨度为2010年4月至9月,直至每个CD4组有150例患者。
450例患者中,71.1%年龄在25至45岁之间。随着CD4水平下降,临床症状更明显。临床症状主要为发热(93%)和体重减轻(62.7%)。第三组患者中肺部空洞形成(59.3%)、浸润(38.7%)以及病变位于肺尖(72%)更为常见。相比之下,第一组患者肺外病变(纵隔淋巴结肿大、胸膜炎)和X线正常(9.3%)更为频繁。如果患者免疫功能低下,空洞形成较少(与CD4>350时的59.3%相比为22.3%)且相关病变增加更为明显。血液学、肝脏、肾脏疾病在免疫功能最低下的患者组中更频繁且更严重。
HIV相关结核病具有非典型的临床、放射学、生物学表现,且在存在显著免疫抑制时病情更严重。